Coupling structure-based design with combinatorial chemistry: application of active site derived pharmacophores with informative library design.
暂无分享,去创建一个
Christian Lemmen | John E Eksterowicz | Erik Evensen | G Patrick Brady | J Kevin Lanctot | Erin K Bradley | Eddine Saiah | Leslie A Robinson | Peter D J Grootenhuis | Jeffrey M Blaney | C. Lemmen | E. Bradley | P. Grootenhuis | J. Blaney | G. Brady | J. Eksterowicz | Erik Evensen | J. Lanctôt | E. Saiah | L. Robinson
[1] S. Kim,et al. High-resolution crystal structures of human cyclin-dependent kinase 2 with and without ATP: bound waters and natural ligand as guides for inhibitor design. , 1996, Journal of medicinal chemistry.
[2] Philip D. Jeffrey,et al. Crystal structure of the p27Kip1 cyclin-dependent-kinase inibitor bound to the cyclin A–Cdk2 complex , 1996, Nature.
[3] J. Mason,et al. New 4-point pharmacophore method for molecular similarity and diversity applications: overview of the method and applications, including a novel approach to the design of combinatorial libraries containing privileged substructures. , 1999, Journal of medicinal chemistry.
[4] M. Karplus,et al. Functionality maps of binding sites: A multiple copy simultaneous search method , 1991, Proteins.
[5] J S Mason,et al. Library design and virtual screening using multiple 4-point pharmacophore fingerprints. , 1999, Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing.
[6] D. Osguthorpe,et al. Structure and energetics of ligand binding to proteins: Escherichia coli dihydrofolate reductase‐trimethoprim, a drug‐receptor system , 1988, Proteins.
[7] Steven L. Teig. Informative Libraries are More Useful than Diverse Ones , 1998 .
[8] Gennady M Verkhivker,et al. Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: conformationally flexible docking by evolutionary programming. , 1995, Chemistry & biology.
[9] Robert Stanton,et al. Conformational analysis by intersection: CONAN , 2003, J. Comput. Chem..
[10] Philip M. Dean,et al. Three-dimensional hydrogen-bond geometry and probability information from a crystal survey , 1996, J. Comput. Aided Mol. Des..
[11] L Meijer,et al. Inhibition of cyclin-dependent kinases, GSK-3beta and CK1 by hymenialdisine, a marine sponge constituent. , 2000, Chemistry & biology.
[12] T. Kennedy. Managing the drug discovery/development interface , 1997 .
[13] S H Kim,et al. Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors. , 1998, Science.
[14] S. Elledge,et al. Inhibition of cyclin-dependent kinases by p21. , 1995, Molecular biology of the cell.
[16] F. Bushman,et al. Developing a dynamic pharmacophore model for HIV-1 integrase. , 2000, Journal of medicinal chemistry.
[17] D. Kostrewa,et al. Novel inhibitors of DNA gyrase: 3D structure based biased needle screening, hit validation by biophysical methods, and 3D guided optimization. A promising alternative to random screening. , 2000, Journal of medicinal chemistry.
[18] Arup K. Ghose,et al. Adapting Structure-Based Drug Design in the Paradigm of Combinatorial Chemistry and High-Throughput Screening: An Overview and New Examples with Important Caveats for Newcomers to Combinatorial Library Design Using Pharmacophore Models or Multiple Copy Simultaneous Search Fragments , 1999 .
[19] J. Ippolito,et al. Hydrogen bond stereochemistry in protein structure and function. , 1990, Journal of molecular biology.
[20] Malcolm J. McGregor,et al. Pharmacophore Fingerprinting. 1. Application to QSAR and Focused Library Design , 1999, J. Chem. Inf. Comput. Sci..
[21] Jonathan S. Mason,et al. Ligand-Receptor 3-D Similarity Studies Using Multiple 4-Point Pharmacophores , 1998, Pacific Symposium on Biocomputing.
[22] J. H. Van Drie,et al. Addressing the Challenges Posed by Combinatorial Chemistry: 3D Databases, Pharmacophore Recognition and Beyond , 1998 .
[23] Pieter F. W. Stouten,et al. Fast prediction and visualization of protein binding pockets with PASS , 2000, J. Comput. Aided Mol. Des..